- Home
- FDMT vs CPS Comparison
FDMT vs CPS Comparison
Compare FDMT & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | CPS |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 547.2M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FDMT | CPS |
|---|---|---|
| Price | $8.83 | $28.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $31.71 | ★ $51.88 |
| AVG Volume (30 Days) | ★ 652.3K | 167.0K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.79 | ★ 94.87 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | $4.42 |
| Revenue Next Year | $70.28 | $6.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $3.03 | $14.50 |
| 52 Week High | $12.34 | $47.98 |
Technical Indicators
Market Signals| Indicator | FDMT | CPS |
|---|---|---|
| Relative Strength Index (RSI) | 40.43 | 42.74 |
| Support Level | $8.25 | $27.86 |
| Resistance Level | $10.70 | $31.80 |
| Average True Range (ATR) | 0.49 | 1.53 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 4.95 | 13.19 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.